These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24116909)

  • 21. Neuromedin U (NMU) regulates osteoblast differentiation and activity.
    Hsiao YT; Jestes KJ; Jackson KL; Zukosky T; Squire ME; Hum JM; Lowery JW
    Biochem Biophys Res Commun; 2020 Apr; 524(4):890-894. PubMed ID: 32057362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis.
    Liu WJ; Jiang ZM; Chen Y; Xiao PT; Wang ZY; Huang TQ; Liu EH
    J Ethnopharmacol; 2020 Jul; 257():112871. PubMed ID: 32325182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospect of mesenchymal stem cells in therapy of osteoporosis: A review.
    Aghebati-Maleki L; Dolati S; Zandi R; Fotouhi A; Ahmadi M; Aghebati A; Nouri M; Kazem Shakouri S; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):8570-8578. PubMed ID: 30488448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
    Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
    Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.
    Chen Y; Xiao H; Liu Z; Teng F; Yang A; Geng B; Sheng X; Xia Y
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis.
    Wu W; Xiao Z; Chen Y; Deng Y; Zeng D; Liu Y; Huang F; Wang J; Liu Y; Bellanti JA; Rong L; Zheng SG
    Mol Ther; 2020 Jun; 28(6):1518-1532. PubMed ID: 32304668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-analgesic effects of opioids: the interaction of opioids with bone and joints.
    Mattia C; Di Bussolo E; Coluzzi F
    Curr Pharm Des; 2012; 18(37):6005-9. PubMed ID: 22747537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis and fractures in systemic lupus erythematosus.
    Bultink IE
    Arthritis Care Res (Hoboken); 2012 Jan; 64(1):2-8. PubMed ID: 22213721
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of genetic factors in the pathogenesis of osteoporosis.
    Stewart TL; Ralston SH
    J Endocrinol; 2000 Aug; 166(2):235-45. PubMed ID: 10927613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of bone quality--present and future].
    Ito M
    Clin Calcium; 2004 Dec; 14(12):27-32. PubMed ID: 15577170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis: The Result of an 'Aged' Bone Microenvironment.
    Yu B; Wang CY
    Trends Mol Med; 2016 Aug; 22(8):641-644. PubMed ID: 27354328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis.
    Yuan Y; Chen X; Zhang L; Wu J; Guo J; Zou D; Chen B; Sun Z; Shen C; Zou J
    Prog Biophys Mol Biol; 2016 Nov; 122(2):122-130. PubMed ID: 26657214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of gene therapy for fracture healing in osteoporosis.
    Egermann M; Schneider E; Evans CH; Baltzer AW
    Osteoporos Int; 2005 Mar; 16 Suppl 2():S120-8. PubMed ID: 15654580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis.
    Kiernan J; Hu S; Grynpas MD; Davies JE; Stanford WL
    Stem Cells Transl Med; 2016 May; 5(5):683-93. PubMed ID: 26987353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoclasts: more than 'bone eaters'.
    Charles JF; Aliprantis AO
    Trends Mol Med; 2014 Aug; 20(8):449-59. PubMed ID: 25008556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone scaffolds loaded with siRNA-Semaphorin4d for the treatment of osteoporosis related bone defects.
    Zhang Y; Wei L; Miron RJ; Shi B; Bian Z
    Sci Rep; 2016 Jun; 6():26925. PubMed ID: 27254469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects.
    Oh WT; Yang YS; Xie J; Ma H; Kim JM; Park KH; Oh DS; Park-Min KH; Greenblatt MB; Gao G; Shim JH
    Mol Ther; 2023 Feb; 31(2):435-453. PubMed ID: 36184851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone histomorphometry: a concise review for endocrinologists and clinicians.
    Kulak CA; Dempster DW
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):87-98. PubMed ID: 20485895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical utility of bone marker measurements in osteoporosis.
    Wheater G; Elshahaly M; Tuck SP; Datta HK; van Laar JM
    J Transl Med; 2013 Aug; 11():201. PubMed ID: 23984630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Extracellular Vesicles (EVs) in the Epigenetic Regulation of Bone Metabolism and Osteoporosis.
    Muraca M; Cappariello A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.